
Elixir Medical’s DynamX Bioadaptor Outperforms Drug-Eluting Stent in Acute Coronary Syndrome Patients
Elixir Medical, known for its innovative technologies in treating cardiovascular disease, has announced compelling late-breaking data showcasing the advantages of the DynamX® Coronary Bioadaptor System over the Resolute Onyx™ zotarolimus drug-eluting stent (DES) in reducing target lesion failure (TLF) among…












